AREV Life Sciences Global Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AREV.CN research report →
Companywww.arevlifesciences.com
AREV Life Sciences Global Corp. , an integrated life science discovery company, produces and sells functional ingredients in Canada. The company's CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles.
- CEO
- Michael C. Withrow
- IPO
- 2000
- Employees
- 2
- HQ
- Coquitlam, BC, CA
Price Chart
Valuation
- Market Cap
- $2.84M
- P/E
- -1.87
- P/S
- 57.79
- P/B
- -2.84
- EV/EBITDA
- -2.18
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -155.72%
- Op Margin
- -2839.86%
- Net Margin
- -2940.37%
- ROE
- 276.09%
- ROIC
- 150.98%
Growth & Income
- Revenue
- $49.11K · -80.74%
- Net Income
- $-1,444,106 · -39.32%
- EPS
- $-0.05 · 9.26%
- Op Income
- $-1,394,738
- FCF YoY
- 75.29%
Performance & Tape
- 52W High
- $0.09
- 52W Low
- $0.09
- 50D MA
- $0.09
- 200D MA
- $0.09
- Beta
- 2.55
- Avg Volume
- 0
Get TickerSpark's AI analysis on AREV.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AREV.CN Coverage
We haven't published any research on AREV.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AREV.CN Report →